Swords Douglas S, Bednarski Brian K, Messick Craig A, Tillman Matthew M, Chang George J, You Y Nancy
Department of Surgical Oncology, University of Texas MD Anderson Cancer, Houston, TX, USA.
Department of Colon and Rectal Surgery, University of Texas MD Anderson Cancer, Houston, TX, USA.
Ann Surg Oncol. 2022 Jan;29(1):706-716. doi: 10.1245/s10434-021-10643-5. Epub 2021 Aug 18.
Lower socioeconomic status (SES) is associated with shorter overall survival (OS) in patients with locoregional colon cancer. We aimed to estimate: (1) the proportion of SES-based OS disparities mediated by disparities in the quality and location of surgical treatment in patients with resected stage I-III colon cancer and (2) the relative importance of components of surgical quality.
We examined patients ages 18-80 years with resected stage I-III colon adenocarcinoma using the 2010-2016 National Cancer Database. SES was defined at the zip code level. Inverse odds weighting mediation analysis was used to estimate the proportion mediated (PM) for nine treatment quality-related and facility-related factors and composite PMs in models including all nine mediators. Models compared high SES patients with each lower SES stratum.
Among 171,009 patients, 5-year OS increased from 70.4% in low SES patients to 78.1% in high SES. When high SES patients were compared with low, lower-middle, and upper-middle SES patients, PM ranges among lower SES strata were: minimally invasive surgery 16.0-16.6%, lymph nodes examined 7.7-9.6%, positive margins 3.8-6.5%, length of stay 16.7-28.1%, readmissions insignificant to 3.7%, treatment at > 1 CoC facility 2.7-3.1%, facility type insignificant to 7.3%, facility volume 2.9-8.2%, and adjusted facility 90-day mortality rates 33.2-42.8%. Composite PMs were 76.9% (95% CI 61.3%, 92.4%) for low SES, 68.7% (95% CI 56.4%, 81.1%) for lower-middle SES, and 60.9% (95% CI 43.1%, 78.6%) for upper-middle SES.
These data suggest that improving the quality of the surgical episode for disadvantaged patients undergoing resection for locoregional colon cancer could decrease SES-based survival disparities by over half.
社会经济地位较低(SES)与局部区域性结肠癌患者的总生存期(OS)较短有关。我们旨在评估:(1)在接受手术切除的I - III期结肠癌患者中,基于SES的OS差异中有多少是由手术治疗质量和部位差异所介导的;(2)手术质量各组成部分的相对重要性。
我们使用2010 - 2016年国家癌症数据库,对年龄在18 - 80岁、接受手术切除的I - III期结肠腺癌患者进行了研究。SES在邮政编码层面进行定义。采用逆概率加权中介分析来估计九个与治疗质量和医疗机构相关因素的中介比例(PM)以及包含所有九个中介因素的模型中的综合PM。模型将高SES患者与每个较低SES阶层进行比较。
在171,009例患者中,5年总生存率从低SES患者的70.4%升至高SES患者的78.1%。当将高SES患者与低、中低和中高SES患者进行比较时,较低SES阶层的PM范围为:微创手术16.0 - 16.6%,检查淋巴结数量7.7 - 9.6%,切缘阳性3.8 - 6.5%,住院时间16.7 - 28.1%,再次入院率无显著差异至3.7%,在>1个癌症委员会(CoC)认证机构接受治疗2.7 - 3.1%,医疗机构类型无显著差异至7.3%,医疗机构规模2.9 - 8.2%,以及调整后的医疗机构90天死亡率33.2 - 42.8%。低SES的综合PM为76.9%(95%CI 61.3%,92.4%),中低SES为68.7%(95%CI 56.4%,81.1%),中高SES为60.9%(95%CI 43.1%,78.6%)。
这些数据表明,提高接受局部区域性结肠癌切除术的弱势患者的手术治疗质量,可使基于SES的生存差异减少一半以上。